Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework
Authors
Andrei Oros
Domenico Bruno (ORCID: https://orcid.org/0000-0003-0898-182X)
Jam Suba
Marion Fahey (ORCID: https://orcid.org/0000-0001-8758-1917)
Catherine W. Gillespie (ORCID: https://orcid.org/0000-0002-6653-1301)
Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework
Andrei Oros, Domenico Bruno, Jam Suba, Marion Fahey et al.
Citations
11 citations
Journal
EClinicalMedicine
Topics
Respiratory viral infections research
Field-Weighted Citation Impact (FWCI)
14.90
article
Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework
Andrei Oros, Domenico Bruno, Jam Suba, Marion Fahey, Catherine W. Gillespie, Mariana Haeberer, Susan McLaughlin, Caihua Liang, Ana Gabriela Grajales, Bradford D. Gessner, Katrin Burkart, Elizabeth Begier, Quinn Rafferty, Asuka Yoshida, Caroline Lade
article en
11 citations
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 85
Institutions
Pfizer (United States) (US), University of Washington (US), Institute for Health Metrics and Evaluation (US), Pfizer (Germany) (DE), Pfizer (Spain) (ES), Pfizer (Japan) (JP), Pfizer (Canada) (CA), Global Vaccines (United States) (US), Pfizer (Ireland) (IE), Seattle University (US)